Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
DaVita Stock Quote

DaVita (NYSE: DVA)

$129.96
(-0.4%)
-$0.46
Price as of April 15, 2024, 4:00 p.m. ET

DaVita Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
DVA +54.79% +154.57% +20.55% +3,100%
S&P +22.34% +74.52% +11.78% +770%

DaVita Company Info

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

News & Analysis

The Fool has written over 100 articles on DaVita.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.